Atlas Trials

To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability

Clinical trial NCT05856058 · COMPLETED

Trial details

NCT number
NCT05856058
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Graft-versus-host Disease
Start date
2023-05-29
Primary completion
2023-07-03
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.